Publication: Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions
| dc.contributor.author | Salmas, Ramin Ekhteiari | |
| dc.contributor.author | Yurtsever, Mine | |
| dc.contributor.author | Stein, Matthias Jeanette | |
| dc.contributor.author | Durdagi, Serdar | |
| dc.contributor.institution | Salmas, Ramin Ekhteiari, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Yurtsever, Mine, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey | |
| dc.contributor.institution | Stein, Matthias Jeanette, Molecular Simulations and Design Group, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany | |
| dc.contributor.institution | Durdagi, Serdar, Molecular Simulations and Design Group, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey | |
| dc.date.accessioned | 2025-10-05T16:32:07Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | Homology model structures of the dopamine D2 receptor (D2R) were generated starting from the active and inactive states of β2-adrenergic crystal structure templates. To the best of our knowledge, the active conformation of D2R was modeled for the first time in this study. The homology models are built and refined using MODELLER and ROSETTA programs. Top-ranked models have been validated with ligand docking simulations and in silico Alanine-scanning mutagenesis studies. The derived extra-cellular loop region of the protein models is directed toward the binding site cavity which is often involved in ligand binding. The binding sites of protein models were refined using induced fit docking to enable the side-chain refinement during ligand docking simulations. The derived models were then tested using molecular modeling techniques on several marketed drugs for schizophrenia. Alanine-scanning mutagenesis and molecular docking studies gave similar results for marketed drugs tested. We believe that these new D2 receptor models will be very useful for a better understanding of the mechanisms of action of drugs to be targeted to the binding sites of D2Rs and they will contribute significantly to drug design studies involving G-protein-coupled receptors in the future. © 2016 Elsevier B.V., All rights reserved. | |
| dc.identifier.doi | 10.1007/s11030-015-9569-3 | |
| dc.identifier.endpage | 332 | |
| dc.identifier.issn | 13811991 | |
| dc.identifier.issn | 1573501X | |
| dc.identifier.issue | 2 | |
| dc.identifier.pubmed | 25652238 | |
| dc.identifier.scopus | 2-s2.0-84939987863 | |
| dc.identifier.startpage | 321 | |
| dc.identifier.uri | https://doi.org/10.1007/s11030-015-9569-3 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14719/12763 | |
| dc.identifier.volume | 19 | |
| dc.language.iso | en | |
| dc.publisher | Kluwer Academic Publishers | |
| dc.relation.source | Molecular Diversity | |
| dc.subject.authorkeywords | Alanine-scanning Mutagenesis | |
| dc.subject.authorkeywords | Dopamine D2 Receptor | |
| dc.subject.authorkeywords | G-protein-coupled Receptors | |
| dc.subject.authorkeywords | Homology Modeling | |
| dc.subject.authorkeywords | Molecular Docking Simulations | |
| dc.subject.authorkeywords | Ligands | |
| dc.subject.authorkeywords | Receptors, Dopamine D2 | |
| dc.subject.authorkeywords | Dopamine 2 Receptor | |
| dc.subject.authorkeywords | Ligand | |
| dc.subject.authorkeywords | Protein Binding | |
| dc.subject.authorkeywords | Amino Acid Sequence | |
| dc.subject.authorkeywords | Chemical Phenomena | |
| dc.subject.authorkeywords | Chemical Structure | |
| dc.subject.authorkeywords | Chemistry | |
| dc.subject.authorkeywords | Conformation | |
| dc.subject.authorkeywords | Drug Development | |
| dc.subject.authorkeywords | Genetics | |
| dc.subject.authorkeywords | Human | |
| dc.subject.authorkeywords | Hydrogen Bond | |
| dc.subject.authorkeywords | Metabolism | |
| dc.subject.authorkeywords | Molecular Genetics | |
| dc.subject.authorkeywords | Procedures | |
| dc.subject.authorkeywords | Protein Engineering | |
| dc.subject.authorkeywords | Reproducibility | |
| dc.subject.authorkeywords | Sequence Alignment | |
| dc.subject.authorkeywords | Amino Acid Sequence | |
| dc.subject.authorkeywords | Drug Discovery | |
| dc.subject.authorkeywords | Humans | |
| dc.subject.authorkeywords | Hydrogen Bonding | |
| dc.subject.authorkeywords | Hydrophobic And Hydrophilic Interactions | |
| dc.subject.authorkeywords | Ligands | |
| dc.subject.authorkeywords | Models, Molecular | |
| dc.subject.authorkeywords | Molecular Conformation | |
| dc.subject.authorkeywords | Molecular Sequence Data | |
| dc.subject.authorkeywords | Molecular Structure | |
| dc.subject.authorkeywords | Protein Binding | |
| dc.subject.authorkeywords | Protein Engineering | |
| dc.subject.authorkeywords | Receptors, Dopamine D2 | |
| dc.subject.authorkeywords | Reproducibility Of Results | |
| dc.subject.authorkeywords | Sequence Alignment | |
| dc.subject.indexkeywords | dopamine 2 receptor | |
| dc.subject.indexkeywords | ligand | |
| dc.subject.indexkeywords | protein binding | |
| dc.subject.indexkeywords | amino acid sequence | |
| dc.subject.indexkeywords | chemical phenomena | |
| dc.subject.indexkeywords | chemical structure | |
| dc.subject.indexkeywords | chemistry | |
| dc.subject.indexkeywords | conformation | |
| dc.subject.indexkeywords | drug development | |
| dc.subject.indexkeywords | genetics | |
| dc.subject.indexkeywords | human | |
| dc.subject.indexkeywords | hydrogen bond | |
| dc.subject.indexkeywords | metabolism | |
| dc.subject.indexkeywords | molecular genetics | |
| dc.subject.indexkeywords | procedures | |
| dc.subject.indexkeywords | protein engineering | |
| dc.subject.indexkeywords | reproducibility | |
| dc.subject.indexkeywords | sequence alignment | |
| dc.subject.indexkeywords | Amino Acid Sequence | |
| dc.subject.indexkeywords | Drug Discovery | |
| dc.subject.indexkeywords | Humans | |
| dc.subject.indexkeywords | Hydrogen Bonding | |
| dc.subject.indexkeywords | Hydrophobic and Hydrophilic Interactions | |
| dc.subject.indexkeywords | Ligands | |
| dc.subject.indexkeywords | Models, Molecular | |
| dc.subject.indexkeywords | Molecular Conformation | |
| dc.subject.indexkeywords | Molecular Sequence Data | |
| dc.subject.indexkeywords | Molecular Structure | |
| dc.subject.indexkeywords | Protein Binding | |
| dc.subject.indexkeywords | Protein Engineering | |
| dc.subject.indexkeywords | Receptors, Dopamine D2 | |
| dc.subject.indexkeywords | Reproducibility of Results | |
| dc.subject.indexkeywords | Sequence Alignment | |
| dc.title | Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions | |
| dc.type | Article | |
| dcterms.references | Römpler, Holger, G protein-coupled time travel: Evolutionary aspects of GPCR research, Molecular Interventions, 7, 1, pp. 17-25, (2007), Congreve, Miles S., The impact of GPCR structures on pharmacology and structure-based drug design, British Journal of Pharmacology, 159, 5, pp. 986-996, (2010), Overington, John P., How many drug targets are there?, Nature Reviews Drug Discovery, 5, 12, pp. 993-996, (2006), Schiöth, Helgi Birgir, Structural diversity of g proteincoupled receptors and significance for drug discovery, Nature Reviews Drug Discovery, 7, 4, pp. 339-357, (2008), Rasmussen, Sǒren G.F., Crystal structure of the β 2 adrenergic receptor-Gs protein complex, Nature, 477, 7366, pp. 549-557, (2011), Jaakola, Veli Pekka, The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist, Science, 322, 5905, pp. 1211-1217, (2008), Haga, Kazuko, Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist, Nature, 482, 7386, pp. 547-551, (2012), Park, Jung-hee, Crystal structure of the ligand-free G-protein-coupled receptor opsin, Nature, 454, 7201, pp. 183-187, (2008), Scheerer, Patrick, Crystal structure of opsin in its G-protein-interacting conformation, Nature, 455, 7212, pp. 497-502, (2008), Jackson, David M., Dopamine receptors: Molecular biology, biochemistry and behavioural aspects, Pharmacology and Therapeutics, 64, 2, pp. 291-370, (1994) | |
| dspace.entity.type | Publication | |
| local.indexed.at | Scopus | |
| person.identifier.scopus-author-id | 56338023600 | |
| person.identifier.scopus-author-id | 56067383000 | |
| person.identifier.scopus-author-id | 7402996760 | |
| person.identifier.scopus-author-id | 22955598300 |
